(Q98205148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

title

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

1 reference

Xavier de Lamballerie

7

object named as

Xavier de Lamballerie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

author name string

Franck Touret

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Magali Gilles

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Karine Barral

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Antoine Nougairède

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Jacques van Helden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Etienne Decroly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

Bruno Coutard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

publication date

4 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

page(s)

13093

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

10 August 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Lack of Antiviral Activity of Darunavir against SARS-CoV-2

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS): Protocol for a Pragmatic, Open Label, Active Comparator Trial

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

The coronavirus pandemic in five powerful charts

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Clinical Characteristics of Coronavirus Disease 2019 in China

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Improving therapy of severe infections through drug repurposing of synergistic combinations

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Phylogenetically based establishment of a dengue virus panel, representing all available genotypes, as a tool in dengue drug discovery

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Nicotine and the renin-angiotensin system

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Drug Repurposing for Viral Infectious Diseases: How Far Are We?

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Cell-line dependent antiviral activity of sofosbuvir against Zika virus

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

SARS and MERS: recent insights into emerging coronaviruses

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Arbidol as a broad-spectrum antiviral: an update

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7403393

Distribution of chromosome 18 and X centric heterochromatin in the interphase nucleus of cultured human cells

10 February 2021

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-020-70143-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-020-70143-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-020-70143-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/S41598-020-70143-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32753646%20AND%20SRC:MED&resulttype=core&format=json

10 August 2020

PubMed publication ID

32753646

1 reference